| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 32,625 | 19,391 | | Cost of Revenue | 12,981 | 7,650 | | | Gross Profit | 19,645 | 11,741 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 14,545 | 8,876 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 5,100 | 2,865 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 79 | 23 | | Earnings Before Interest And Taxes | 5,179 | 2,888 | | Interest Expense |
-
| 28 | | Income Before Tax | 5,179 | 2,860 | | Income Tax Expense | 1,825 | (1,663) | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 3,354 | 4,523 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 3,354 | 4,523 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $3,354 | $4,523 |
|
0.25% Nasdaq 
Income Statement
